Posaconazole Tablets bulk supplier for pharma manufacturers

Posaconazole Tablets 300 mg Suppliers & Bulk Manufacturers

Available Forms: Delayed-Release Tablets

Available Strengths: 300 mg

Reference Brands: Noxafil(US & EU)

Posaconazole delayed-release tablets inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. They provide broad-spectrum antifungal activity, improved absorption, and enhanced bioavailability. Benefits include effective prophylaxis and treatment of invasive fungal infections, with convenient dosing, making them vital for managing severe fungal diseases.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Posaconazole Tablets? List it or send an offer →

Product Description:

Posaconazole delayed-release tablets are approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. We facilitate efficient market access for posaconazole delayed-release tablets, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Posaconazole Tablets — third party manufacturing & bulk supply

Posaconazole Tablets 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Posaconazole Tablets is supplied as Delayed-Release Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Posaconazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Posaconazole Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Posaconazole is used to prevent and treat severe fungal infections, especially in patients with weakened immune systems such as those undergoing chemotherapy, stem-cell transplant, or with hematologic malignancies. It is effective against invasive aspergillosis, mucormycosis, and difficult-to-treat Candida infections, and is often chosen when other antifungal therapies are not sufficient or not tolerated.

Posaconazole contains the active triazole antifungal compound posaconazole. It is formulated with pharmaceutical excipients that improve its absorption and ensure consistent systemic exposure for effective antifungal activity.

The primary trade name for posaconazole is Noxafil, widely recognized in the USA, EU, UK, and many other markets.

Noxafil is manufactured by Merck & Co. (MSD). Generic posaconazole is also produced by various GMP-certified pharmaceutical manufacturers around the world.

The generic name is posaconazole.

The main brand name is Noxafil.

Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, and also by multiple approved global GMP manufacturers that produce generic posaconazole for international distribution.